Nicolas Charloteaux - 28 Sep 2020
Currently there are around 27 different companies, large as well as small and medium enterprises, working to develop vaccines against COVID-19, including members of Vaccines Europe. Some are working on more than one approach to develop a vaccine, utilizing different technologies, partnerships and close collaborations with others.
The pharmaceutical industry continues to research and invest in finding new vaccines for COVID-19.
No one company can address this problem alone. This requires a global collaborative effort, and the more approaches that move forward, the more we will increase our chances of success.
Members area
